James River Group Holdings (JRVR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual General Meeting scheduled for October 24, 2024, with proxy materials distributed starting September 18, 2024.
Shareholders will vote on six key proposals, including director elections, auditor re-appointment, executive compensation, and amendments to incentive plans.
Board recommends voting in favor of all proposals and encourages shareholder participation via multiple voting methods.
Voting matters and shareholder proposals
Election of eight directors for a one-year term until the 2025 meeting.
Re-appointment of Ernst & Young LLP as independent auditor and authorization for the Board to set remuneration.
Advisory vote on 2023 executive compensation and on the frequency of future say-on-pay votes (Board recommends annual vote).
Amendments to the 2014 Long-Term Incentive Plan and 2014 Non-Employee Director Incentive Plan to increase share authorizations.
Board’s recommendations are “FOR” all proposals and “one year” for say-on-pay frequency.
Board of directors and corporate governance
Eight nominees, including CEO and Non-Executive Chairman, with diverse backgrounds in insurance, finance, and governance.
Board composition: 37.5% gender diverse, 12.5% underrepresented minorities, goal to reach 30% gender diversity by 2025.
Board committees: Audit, Compensation and Human Capital, Nominating and Corporate Governance, and Investment.
Annual board and committee self-assessments; all directors attended at least 75% of meetings.
Share ownership guidelines require directors and executives to hold significant equity stakes.
Latest events from James River Group Holdings
- 2025 marked a sharp turnaround to profitability, capital growth, and E&S-driven operational gains.JRVR
Q4 202527 Mar 2026 - Earnings rose on investment gains and strategic actions, but reserve and legal risks persist.JRVR
Q2 20242 Feb 2026 - Q3 2024 net loss of $40.7M driven by reserve charges, reinsurance, and strategic capital actions.JRVR
Q3 202415 Jan 2026 - Over 21 million common shares registered for resale by major investors, with no proceeds to the company.JRVR
Registration Filing16 Dec 2025 - Q4 2024 net loss of $92.7M; E&S premiums top $1B; 2025 outlook positive.JRVR
Q4 202416 Dec 2025 - Proxy covers director elections, auditor re-appointment, compensation, and plan amendments.JRVR
Proxy Filing2 Dec 2025 - Q1 net income dropped to $9M as E&S pricing rose and Specialty Admitted premiums declined.JRVR
Q1 202524 Nov 2025 - Q2 2025 saw $11.7M adjusted net income, 14% return, and record E&S premiums amid strategic changes.JRVR
Q2 202523 Nov 2025 - Strong underwriting and cost discipline drove a 19.3% return and 94% combined ratio.JRVR
Q3 202514 Nov 2025